男
2021VTQCID34
负责药品类别及治疗领域
化学药品,D0115
BU
HEMA-MAX
药品上市许可持有人
Janssen-Cilag International NV
长期
否
靳家成
Collaborating in more than 150 countries.
By clicking on a link below, you may enter a different part of this website, or a website outside of Janssen.com. These sections or websites are governed by their own Legal and Privacy Policies.
Global
Asia Pacific
Europe, Middle East & Africa (EMEA)
Latin America